# X4 Pharmaceuticals, Inc. (XFOR)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/XFOR/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | $ 2.71M | $ -20.24M | $ 0 | $ 77.25M | $ 168.45M |
| 2025 | $ 35.95M | $ -81.09M | $ -90.74M | $ 77.29M | $ 186.29M |
| 2024 | $ 2.69M | $ -39.36M | $ -137.93M | $ 78.09M | $ 22.15M |
| 2023 | $ 0 | $ -109.39M | $ -104.42M | $ 58.28M | $ 51.10M |
| 2022 | $ 0 | $ -104.86M | $ -86.25M | $ 38.42M | $ 74.05M |
| 2021 | $ 0 | $ -105.43M | $ -85.01M | $ 39.79M | $ 64.41M |
| 2020 | $ 3.82M | $ -79.15M | $ -76.67M | $ 38.45M | $ 72.80M |
| 2019 | $ 0 | $ -68.16M | $ -28.62M | $ 22.91M | $ 129.22M |
| 2018 | $ 0 | $ -43.96M | $ -51.69M | $ 9.83M | $ -11.68M |
| 2017 | $ 0 | $ -45.64M | $ -37.60M | $ 12.24M | $ 58.71M |
| 2016 | $ 0 | $ -4.82M | N/A | N/A | N/A |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.46 |
| Liabilities / Eq | 0.60 |
| Current Ratio | 10.18 |

## Other views

- [Metrics](https://sponda.capital/en/XFOR.md)
- [Charts](https://sponda.capital/en/XFOR/charts.md)
- [Compare](https://sponda.capital/en/XFOR/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-13.